期刊
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
卷 19, 期 3, 页码 205-217出版社
WILEY-BLACKWELL
DOI: 10.1111/jns.12086
关键词
corneal confocal microscopy; corneal nerves; diabetic peripheral neuropathy; nitrotyrosine
资金
- Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX001680-01]
- Rehabilitation Research and Development (Merit award) [RX000889-01]
- Iowa City VA Center of Excellence for the Prevention and Treatment of Visual Loss [C9251-C]
- National Institute of Diabetes and Digestive and Kidney Diseases from National Institutes of Health [DK081147]
We sought to determine the impact that duration of hyperglycemia and control has on corneal nerve fiber density in relation to standard diabetic neuropathy endpoints. Control and streptozotocin-diabetic C57Bl/6J mice were analyzed after 4, 8, 12, and 20weeks. For the 20-week time point, five groups of mice were compared: control, untreated diabetic, and diabetic treated with insulin designated as having either poor glycemic control, good glycemic control, or poor glycemic control switched to good glycemic control. Hyperglycemia was regulated by use of insulin-releasing pellets. Loss of corneal nerves in the sub-epithelial nerve plexus or corneal epithelium progressed slowly in diabetic mice requiring 20weeks to reach statistical significance. In comparison, slowing of motor and sensory nerve conduction velocity developed rapidly with significant difference compared with control mice observed after 4 and 8weeks of hyperglycemia, respectively. In diabetic mice with good glycemic control, average blood glucose levels over the 20-week experimental period were lowered from 589 +/- 2 to 251 +/- 9mg/dl. All diabetic neuropathy endpoints examined were improved in diabetic mice with good glycemic control compared with untreated diabetic mice. However, good control of blood glucose was not totally sufficient in preventing diabetic neuropathy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据